Quarton International advised humediQ global GmbH on the sale to Varian Medical Systems, Inc.

Tombstone humediq 2018 englisch
Overview

Transaction

Munich – Quarton International advised the sole shareholder of humediQ global GmbH (“humediQ”) on the sale of all shares to Varian Medical Systems, Inc. (“Varian”), a global leader in the radiotherapy of tumor diseases.

Client

humediQ, headquartered in Munich, Germany, is focused on the development, production and sales of hardware and software solutions for quality assurance in radiotherapy. Key product of humediQ is IDENTIFY, an automated patient identification, positioning and motion management system for radiation therapy. IDENTIFY incorporates patient safety, quality, efficiency and surface-guided features in an automated workflow solution for surface-guided radiation therapy (SGRT). The IDENTIFY system features a palm reader for patient identification, a radio frequency identification (RFID) reader for proper accessory verification and placement on the treatment couch, automatic synchronization with the oncology information system, and SGRT cameras for proper patient positioning and motion monitoring throughout the treatment. For more information, visit www.humediq.com

Tombstone humediq 2018 Transaktion deutsch

Buyer

Varian, headquartered in Palo Alto, California, is a leader in developing and delivering hardware and software products for the treatment of cancer with radiotherapy, stereotactic radiosurgery, stereotactic body radiotherapy (SBRT), proton therapy, and brachytherapy. Varian employs approximately 6,500 people around the world. For more information, visit www.varian.com

Logo Varian

Contact

Konstantin
Schönborn

Partner
M&A Quarton, A Cowen Company

+49 89 2000 393 0
Email

Lars
Veit

Partner
M&A Quarton, A Cowen Company

+49 89 2000 393 0
Email

Customer Statements

After Quarton had already successfully organized the sale of my former company Medical Intelligence GmbH to Elekta AB, it was clear for me to trust Quarton's outstanding medical technology know-how and excellent service in this transaction as well. Despite our already high expectations, Quarton exceeded them in every respect, and through their competence and commitment made the transaction an extraordinary success.
Christian Hieronimi
Founder and CEO of humediQ

Similar Transactions

Tombstone Immunomedics Gilead EN
Tombstone hg medical nordholding en
Tombstone Gilead Tizona Transaction 2020 en
Tombstone Medicrea Medtronic Transaction 2020 en
Tombstone Gilead Kronos Transaction 2020 en
Tombstone Transaction MedAvail Myos 2020 en
Transaktion Invitae Archer Transaction 2020 en
Tombstone Gilead Arcus Partnership 2020 en
Tombstone Ecofarmacia Phoenix Transaction 2020 eng
Tombstone Alphatec Eos Transaktion Cowen 2020 en
Tombstones IK Invest Ondal Transaction 2019 en